• Keap1 (PTR2556) Mouse mAb
1 1

Upingbio

YP-Ab-17183-53UL

Keap1 (PTR2556) Mouse mAb

Keap1 (PTR2556) Mouse mAb

$0.00 USD
$0.00 USD
Sale Sold out
Shipping calculated at checkout.
Size
  • Reaction species: Human, Mouse,Rat
  • Gene Name: KEAP1 INRF2 KIAA0132 KLHL19
  • Protein name: Kelch-like ECH-associated protein 1 (Cytosolic inhibitor of Nrf2) (INrf2) (Kelch-like protein 19)
  • Molecular weight (DA): 70kDa
  • Immunogen: Synthesized peptide derived from human Keap1
  • Specificity: This antibody detects endogenous levels of Keap1 at Human, Mouse,Rat
  • Composition: PBS, pH7.4, 50% glycerol, 0.03%Proclin 300
  • Source: Mouse,monoclonal:IgG1,kappa
  • Dilution ratio: WB 1:500-2000 ELISA 1:5000-20000
  • Purification process: Protein G
  • Storage: -20°C/1 year
  • Other Names: Kelch-like ECH-associated protein 1 (Cytosolic inhibitor of Nrf2) (INrf2) (Kelch-like protein 19)
  • Background: kelch like ECH associated protein 1(KEAP1) Homo sapiens This gene encodes a protein containing KELCH-1 like domains, as well as a BTB/POZ domain. Kelch-like ECH-associated protein 1 interacts with NF-E2-related factor 2 in a redox-sensitive manner and the dissociation of the proteins in the cytoplasm is followed by transportation of NF-E2-related factor 2 to the nucleus. This interaction results in the expression of the catalytic subunit of gamma-glutamylcysteine synthetase. Two alternatively spliced transcript variants encoding the same isoform have been found for this gene. [provided by RefSeq, Jul 2008],
  • Function: disease:Defects in KEAP1 may be a cause of breast cancer.,disease:Defects in KEAP1 may be involved in non small cell lung carcinomas (NSCLC) and lung adenocarcinoma.,domain:The Kelch repeats mediate interaction with NF2L2/NRF2, BPTF and PGAM5.,enzyme regulation:Ubiquitination and subsequent degradation of PGAM5 is inhibited by oxidative stress and sulforaphane.,function:Retains NFE2L2/NRF2 in the cytosol. Functions as substrate adapter protein for the E3 ubiquitin ligase complex formed by CUL3 and RBX1. Targets NFE2L2/NRF2 for ubiquitination and degradation by the proteasome, thus resulting in the suppression of its transcriptional activity and the repression of antioxidant response element-mediated detoxifying enzyme gene expression. May also retain BPTF in the cytosol. Targets PGAM5 for ubiquitination and degradation by the proteasome.,PTM:Ubiquitinated and subject to proteasomal degra
View full details